Phase 3 biotech focused on rare diseases caused by mitochondrial dysfunction.
Industry: Health Care
First Day Return: -0.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 12/28/2018 |
Offer Price | $12.00 |
Price Range $12.00 - $14.00 | |
Offer Shares (mm) | 6.5 |
Deal Size ($mm) | $78 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/14/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $78 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Newton, MA, United States |
Founded | 2006 |
Employees at IPO | 57 |
Website www.stealthbt.com |